Ten63 Therapeutics
Until No Patient Is Out of Options
Durham, United States · Founded 2018 · $45.3M raised
- Headquarters
- Durham, North Carolina
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- ten63tx.com
- Total Funding
- $45.3M
- Last Round
- $29.1M Venture RoundFeb 2026
- Rounds
- 3
About
Ten63 Therapeutics is an AI-driven drug discovery company developing therapeutics for previously undruggable targets using its proprietary BEYOND platform. BEYOND fuses quantum simulations with generative chemistry to simulate trillions of potential drug candidates, enabling the company to pursue high-impact targets that are data-poor and experimentally difficult to reach.
Summary
Ten63 Therapeutics is an Artificial Intelligence company based in Durham, United States, founded in 2018. It has raised $45.3M in total across 3 rounds, most recently a $29.1M Venture Round round in Feb 2026. Investors include Chugai Venture Fund, Gates Foundation and Hatteras Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...